{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:16:12Z","timestamp":1740125772564,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01 IP000849-03"],"award-info":[{"award-number":["U01 IP000849-03"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11606-020-06397-7","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T22:02:52Z","timestamp":1611352972000},"page":"2030-2038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-0304","authenticated-orcid":false,"given":"Jessica R.","family":"Cataldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan C.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean T.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Brtnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"issue":"3","key":"6397_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","volume":"67","author":"LA Grohskopf","year":"2018","unstructured":"Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. MMWR Recomm Rep 2018;67(3):1-20.","journal-title":"MMWR Recomm Rep"},{"key":"6397_CR2","unstructured":"Centers for Disease Control and Prevention. Fluzone High-Dose Seasonal Influenza Vaccine. 2018; https:\/\/www.cdc.gov\/flu\/prevent\/qa_fluzone.htm. Accessed Jun 18, 2019, 2019."},{"issue":"5","key":"6397_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14760584.2018.1471989","volume":"17","author":"JKH Lee","year":"2018","unstructured":"Lee JKH, Lam GKL, Shin T, et al. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis. Expert Rev Vaccin 2018;17(5):435-443.","journal-title":"Expert Rev Vaccin"},{"issue":"3","key":"6397_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1473-3099(14)71087-4","volume":"15","author":"HS Izurieta","year":"2015","unstructured":"Izurieta HS, Thadani N, Shay DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 2015;15(3):293-300.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"6397_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cid\/civ261","volume":"61","author":"DM Richardson","year":"2015","unstructured":"Richardson DM, Medvedeva EL, Roberts CB, Linkin DR, Centers for Disease C, Prevention Epicenter P. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans. Clin Infect Dis 2015;61(2):171-176.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"6397_CR6","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/infdis\/jiy088","volume":"217","author":"Y Young-Xu","year":"2018","unstructured":"Young-Xu Y, Van Aalst R, Mahmud SM, et al. Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients. J Infect Dis 2018; 217(11):1718-1727.","journal-title":"J Infect Dis"},{"issue":"9","key":"6397_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","volume":"5","author":"S Gravenstein","year":"2017","unstructured":"Gravenstein S, Davidson HE, Taljaard M, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med 2017; 5(9):738-746.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"6397_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJMoa1315727","volume":"371","author":"CA DiazGranados","year":"2014","unstructured":"DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371(7):635-645.","journal-title":"N Engl J Med"},{"issue":"12","key":"6397_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/14760584.2016.1254044","volume":"15","author":"CA Robertson","year":"2016","unstructured":"Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP. Fluzone(R) High-Dose Influenza Vaccine. Expert Rev Vaccin 2016; 15(12):1495-1505.","journal-title":"Expert Rev Vaccin"},{"issue":"5","key":"6397_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/eurjhf\/hfs207","volume":"15","author":"A Van Ermen","year":"2013","unstructured":"Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 2013; 15(5):560-564.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"6397_CR11","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/cid\/cix1082","volume":"66","author":"Y Natori","year":"2018","unstructured":"Natori Y, Shiotsuka M, Slomovic J, et al. A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients. Clin Infect Dis 2018; 66(11):1698-1704.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"6397_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.vaccine.2015.12.037","volume":"34","author":"S Jamshed","year":"2016","unstructured":"Jamshed S, Walsh EE, Dimitroff LJ, Santelli JS, Falsey AR. Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial. Vaccine. 2016; 34(5):630-635.","journal-title":"Vaccine."},{"issue":"1","key":"6397_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-158-1-201301010-00005","volume":"158","author":"N McKittrick","year":"2013","unstructured":"McKittrick N, Frank I, Jacobson JM, et al. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med 2013; 158(1):19-26.","journal-title":"Ann Intern Med"},{"issue":"36","key":"6397_CR14","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1016\/j.vaccine.2015.07.003","volume":"33","author":"CA DiazGranados","year":"2015","unstructured":"DiazGranados CA, Dunning AJ, Robertson CA, Talbot HK, Landolfi V, Greenberg DP. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty. Vaccine. 2015; 33(36):4565-4571.","journal-title":"Vaccine."},{"issue":"5","key":"6397_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","volume":"65","author":"LA Grohskopf","year":"2016","unstructured":"Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines. MMWR Recomm Rep 2016; 65(5):1-54.","journal-title":"MMWR Recomm Rep"},{"key":"6397_CR16","unstructured":"U.S. Food & Drug Administration. FDA Information Regarding FluMist Quadrivalent Vaccine. 2018; https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/fda-information-regarding-flumist-quadrivalent-vaccine. Accessed Jun 18, 2019, 2019."},{"issue":"32","key":"6397_CR17","first-page":"691","volume":"63","author":"LA Grohskopf","year":"2014","unstructured":"Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63(32):691-697.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"6397_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJMoa065368","volume":"356","author":"RB Belshe","year":"2007","unstructured":"Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356(7):685-696.","journal-title":"N Engl J Med"},{"issue":"10","key":"6397_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","volume":"25","author":"DM Fleming","year":"2006","unstructured":"Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25(10):860-869.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"6397_CR20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","volume":"25","author":"S Ashkenazi","year":"2006","unstructured":"Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25(10):870-879.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"6397_CR21","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1111\/ajt.13505","volume":"15","author":"LA Grohskopf","year":"2015","unstructured":"Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. Am J Transplant 2015; 15(10):2767-2775.","journal-title":"Am J Transplant"},{"issue":"22","key":"6397_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm6522a3","volume":"65","author":"SL Davlin","year":"2016","unstructured":"Davlin SL, Blanton L, Kniss K, et al. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. MMWR Morb Mortal Wkly Rep 2016; 65(22):567-575.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"6397_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0163278707311872","volume":"31","author":"LA Crane","year":"2008","unstructured":"Crane LA, Daley MF, Barrow J, et al. Sentinel physician networks as a technique for rapid immunization policy surveys. Eval Health Prof 2008; 31(1):43-64.","journal-title":"Eval Health Prof"},{"issue":"8","key":"6397_CR24","doi-asserted-by":"publisher","first-page":"e0202755","DOI":"10.1371\/journal.pone.0202755","volume":"13","author":"M Brtnikova","year":"2018","unstructured":"Brtnikova M, Crane LA, Allison MA, Hurley LP, Beaty BL, Kempe A. A method for achieving high response rates in national surveys of U.S. primary care physicians. PLoS One. 2018; 13(8):e0202755.","journal-title":"PLoS One"},{"key":"6397_CR25","doi-asserted-by":"crossref","unstructured":"Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method. Wiley; 2014.","DOI":"10.1002\/9781394260645"},{"issue":"1","key":"6397_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11109-010-9121-1","volume":"33","author":"LR Atkeson","year":"2011","unstructured":"Atkeson LR, Adams AN, Bryant LA, Zilberman L, Saunders KL. Considering mixed mode surveys for questions in political behavior: using the Internet and mail to get quality data at reasonable costs. Polit Behav 2011; 33(1):161-178.","journal-title":"Polit Behav"},{"issue":"4","key":"6397_CR27","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1542\/peds.111.4.e299","volume":"111","author":"SR McMahon","year":"2003","unstructured":"McMahon SR, Iwamoto M, Massoudi MS, et al. Comparison of e-mail, fax, and postal surveys of pediatricians. Pediatrics. 2003; 111(4):e299-e303.","journal-title":"Pediatrics."},{"issue":"3","key":"6397_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/21645515.2015.1011026","volume":"11","author":"LJ McGrath","year":"2015","unstructured":"McGrath LJ, Brookhart MA. On-label and off-label use of high-dose influenza vaccine in the United States, 2010-2012. Hum Vaccin Immunother 2015; 11(3):537-544.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"6397_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.vaccine.2014.10.079","volume":"33","author":"A Chit","year":"2015","unstructured":"Chit A, Roiz J, Briquet B, Greenberg DP. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors. Vaccine. 2015; 33(5):734-741.","journal-title":"Vaccine."},{"issue":"10","key":"6397_CR30","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/jgs.14323","volume":"64","author":"JM Raviotta","year":"2016","unstructured":"Raviotta JM, Smith KJ, DePasse J, et al. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults. J Am Geriatr Soc 2016; 64(10):2126-2131.","journal-title":"J Am Geriatr Soc"},{"key":"6397_CR31","doi-asserted-by":"crossref","unstructured":"Shireman TI, Ogarek J, Gozalo P, et al. Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A\/H1N1-Predominant Influenza Season. J Am Med Dir Assoc 2019.","DOI":"10.1016\/j.jamda.2018.12.003"},{"issue":"51","key":"6397_CR32","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1016\/j.vaccine.2015.10.131","volume":"33","author":"CA DiazGranados","year":"2015","unstructured":"DiazGranados CA, Saway W, Gouaux J, et al. Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age. Vaccine. 2015; 33(51):7188-7193.","journal-title":"Vaccine."},{"issue":"3","key":"6397_CR33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.bbmt.2015.12.003","volume":"22","author":"NB Halasa","year":"2016","unstructured":"Halasa NB, Savani BN, Asokan I, et al. Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 2016; 22(3):528-535.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"6397_CR34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/21645515.2018.1445446","volume":"14","author":"M Bosaeed","year":"2018","unstructured":"Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother 2018; 14(6):1311-1322.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"6397_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/21645515.2018.1520580","volume":"15","author":"JA Pereira","year":"2019","unstructured":"Pereira JA, Gilca V, Waite N, Andrew MK. Canadian older adults' perceptions of effectiveness and value of regular and high-dose influenza vaccines. Hum Vaccin Immunother 2019; 15(2):487-495.","journal-title":"Hum Vaccin Immunother"},{"issue":"24","key":"6397_CR36","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/j.vaccine.2015.04.064","volume":"33","author":"GJ Nowak","year":"2015","unstructured":"Nowak GJ, Sheedy K, Bursey K, Smith TM, Basket M. Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC). Vaccine. 2015; 33(24):2741-2756.","journal-title":"Vaccine."},{"issue":"3","key":"6397_CR37","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1371\/journal.pmed.0030145","volume":"3","author":"EA Almasi","year":"2006","unstructured":"Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. What are the public health effects of direct-to-consumer drug advertising? PLoS Med 2006; 3(3):e145.","journal-title":"PLoS Med"},{"issue":"1","key":"6397_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2105\/AJPH.2008.153767","volume":"100","author":"DL Frosch","year":"2010","unstructured":"Frosch DL, Grande D, Tarn DM, Kravitz RL. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2010; 100(1):24-32.","journal-title":"Am J Public Health"},{"issue":"1","key":"6397_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11606-013-2604-0","volume":"29","author":"AE Faerber","year":"2014","unstructured":"Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. J Gen Intern Med 2014; 29(1):110-118.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"6397_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11606-017-4274-9","volume":"33","author":"K Klara","year":"2018","unstructured":"Klara K, Kim J, Ross JS. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines. J Gen Intern Med 2018; 33(5):651-658.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"6397_CR41","first-page":"669","volume":"36","author":"CL Ventola","year":"2011","unstructured":"Ventola CL. Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? P T 2011; 36(10):669-684.","journal-title":"P T"},{"key":"6397_CR42","unstructured":"Centers for Disease Control and Prevention. Early-Season Flu Vaccination Coverage\u2013United States, November 2018. 2018; https:\/\/www.cdc.gov\/flu\/fluvaxview\/nifs-estimates-nov2018.htm. Accessed Aug 14, 2020, 2020."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06397-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:33:37Z","timestamp":1724362417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06397-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6397"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06397-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None of the authors has any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"None of the authors has any financial disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}